<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03102710</url>
  </required_header>
  <id_info>
    <org_study_id>2015P000685</org_study_id>
    <nct_id>NCT03102710</nct_id>
  </id_info>
  <brief_title>Neuromodulation of Lidocaine and Capsaicin Cream Effects on Pain Experience</brief_title>
  <official_title>Neuromodulation of Placebo and Nocebo Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to use a brain stimulation tool called transcranial direct current
      stimulation (tDCS) to investigate the analgesic (reducing sensitivity to pain) effects of
      lidocaine cream and the hyperalgesic (increasing sensitivity to pain) effects of capsaicin
      cream using a neutral cream as a control. tDCS stimulation has been shown to temporarily
      influence the way the stimulated part of the brain functions. With this method, the
      involvement of specific parts of the brain can be investigated in the working of the brain as
      a whole.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gracely Scale pain rating changes in response to lidocaine and capsaicin creams and tDCS</measure>
    <time_frame>up to 2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of functional connectivity changes of the DLPFC before and after tDCS stimulation</measure>
    <time_frame>up to 2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>tDCS Enhancement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group, the transcranial direct current stimulation (tDCS) stimulates the areas of the brain being examined in this study to increase their activity.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS Inhibition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group, the transcranial direct current stimulation (tDCS) inhibits the areas of the brain being examined in this study to decrease their activity.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham transcranial direct current stimulation (tDCS) does not provide real stimulation though you will not know this until your debriefing at the end of the study. Sham will be used to determine if the results of this study are due to the tDCS or other reasons.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation (tDCS)</intervention_name>
    <description>tCDS safely applies a weak electrical current to your scalp using two sponge electrodes that look like flat circular pads. The pads will be held in place on your head with a neoprene cap. The pads will be attached to a generator that will send a weak stimulus to your scalp. This current influences the way that your brain cells work. When the stimulus starts, you might feel a tingling sensation underneath the electrode pads. That sensation is not painful and goes away in seconds.</description>
    <arm_group_label>tDCS Enhancement</arm_group_label>
    <arm_group_label>tDCS Inhibition</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lidocaine cream</intervention_name>
    <description>Lidocaine cream will be applied on the arm to reduce pain sensitivity (analgesia).</description>
    <arm_group_label>tDCS Enhancement</arm_group_label>
    <arm_group_label>tDCS Inhibition</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Capsaicin cream</intervention_name>
    <description>Capsaicin cream will be applied on the arm to increase pain sensitivity (hyperalgesia).</description>
    <arm_group_label>tDCS Enhancement</arm_group_label>
    <arm_group_label>tDCS Inhibition</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control cream</intervention_name>
    <description>A neutral cream will be applied on the arm as a control.</description>
    <arm_group_label>tDCS Enhancement</arm_group_label>
    <arm_group_label>tDCS Inhibition</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Right handed healthy male and female adults aged 21-50

          -  No contraindications to fMRI scanning

          -  At least a 10th grade English-reading level; English can be a second language provided
             that the patients feel they understand all the questions used in the assessment
             measures.

        Exclusion Criteria:

          -  Current or past history of major medical, neurological, or psychiatric illness

          -  Claustrophobia

          -  History of head trauma

          -  Instability of responses to experimental pain

          -  Non-fluent speaker of English

          -  Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker,
             metal implants, fear of closed spaces, pregnancy

          -  History of alcohol/substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jian Kong</last_name>
    <role>Principal Investigator</role>
    <affiliation>MGH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen Jorgenson</last_name>
    <phone>617-643-7947</phone>
    <email>kjorgenson@mgh.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Charlestown</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Jorgenson, BA</last_name>
      <phone>617-643-7947</phone>
      <email>kjorgenson@partners.org</email>
    </contact>
    <investigator>
      <last_name>Jian Kong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2017</study_first_submitted>
  <study_first_submitted_qc>April 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2017</study_first_posted>
  <last_update_submitted>April 5, 2017</last_update_submitted>
  <last_update_submitted_qc>April 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Jian Kong</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Capsaicin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

